Investigation of Sunesis Pharmaceuticals, Inc. Announced by The Law Offices of Howard G. Smith
July 24 2015 - 2:23PM
Business Wire
Law Offices of Howard G. Smith announces an investigation on
behalf of investors of Sunesis Pharmaceuticals, Inc. ("Sunesis" or
the "Company") (NASDAQ: SNSS). The investigation concerns whether
the Company violated specific sections of the Securities Exchange
Act of 1934 by issuing materially misleading information to the
investing public. Investors who have lost over $50,000 on their
Sunesis investment are encouraged to contact the Law Offices of
Howard G. Smith.
On July 23, 2015, Sunesis announced that the United States Food
and Drug Administration will not approve its blood cancer drug
Qinprezo based on available data, and that the Company must provide
more clinical evidence supporting approval of Qinprezo. On this
news, shares of Sunesis fell $2.25 per share, or more than 70%,
during intraday trading on July 24, 2015. Investors have been
damaged by the alleged fraud of the Company and the Law Offices of
Howard G. Smith is preparing a complaint to seek compensation on
behalf of investors.
If you purchased Sunesis shares, have information or would like
to learn more about these claims, or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at
(888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or
visit our website at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150724005718/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024